Takeda (TSE.4502/NYSE.TAK) today announced that the U.S ... Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living with NT1... About Takeda’s Orexin Franchise ... About Takeda.
About Takeda... ## About Takeda's Orexin Franchise Takeda is spearheading orexin science with the most advanced development program ... ## About Takeda Takeda is focused on creating better health for people and a brighter future for the world.